Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Forum on Immunopathological Diseases and Therapeutics
SJR: 0.309 SNIP: 0.041 CiteScore™: 0.18

ISSN Print: 2151-8017
ISSN Online: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

Forum on Immunopathological Diseases and Therapeutics

DOI: 10.1615/ForumImmunDisTher.2016016605
pages 143-156

Tissue Cross-Talk and Exosomal-MicroRNAs

Micol Marchetti
Bristol Renal, University of Bristol, Dorothy Hocking Building, Whitson Street, BS1 3NY, Bristol, UK


Over the last 10 years, the interest in microRNAs has grown rapidly, and the characterization of these short non-coding RNA sequences has become crucial due to their involvement and role in several widespread diseases such as cancer, cardiovascular diseases, kidney diseases, and diabetes, as well as developmental diseases. The increased understanding of the biology of microRNAs has triggered the development of important tools to study their function and new therapeutic opportunities to treat disease, offering a clear example of how the scientific translational approach plays a crucial role in scientific research in the 21st century. More recently, this interest in microRNAs has increased further as a result of the discovery of exosome microRNAs, microRNAs contained in endogenous vesicles isolated from biological fluids such as breast milk, blood, serum, urine, cerebrospinal fluid, and semen. MicroRNAs represent powerful potential biomarkers for the detection of diseases at an early stage, when the chances of successful treatment and outcomes (drug mediated or surgical) are higher. Furthermore, recent publications have highlighted the role of exosomal microRNAs in cell-to-cell communication, adding new information to the importance of these exosome and vesicles. Much work still needs to be done to better understand the biogenesis and loading and dispersion of exosomes and microvesicles as well to characterize the exosomal content in terms of functionality and activity, but current data already suggest that these exosomes could be potential therapeutic targets.

Articles with similar content:

Noncoding RNAs (ncRNA) in Hepato Cancer: A Review
Journal of Environmental Pathology, Toxicology and Oncology, Vol.37, 2018, issue 1
Xiujuan Sun, Anshoo Malhotra
Tiny Technology Proves Big: A Challenge at Engineering, Medicine and Pharmaceutical Sciences Interface
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.31, 2014, issue 1
Aswini K. Mohapatra, Anjan K. Mahapatra, P. N. Murthy, Supriya Samoju
Surveillance of HPV-Positive Head and Neck Squamous Cell Carcinoma with Circulating and Salivary DNA Biomarkers
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 3-4
Jordan Cheng, Shreerang Bhide, Hisham Mehanna, Paul Nankivell, Yong Kim, Feng Li, David Wong, Nikolas Batis, Kanishka Rao, Daniele Borsetto, Karl Payne
Gain of Antitumor Functions and Induction of Differentiation in Cancer Stem Cells Contribute to Complete Cure and No Relapse
Critical Reviews™ in Oncogenesis, Vol.15, 2009, issue 1-2
Minal Garg
Nanostructured Materials in Drug and Gene Delivery: A Review of the State of the Art
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.28, 2011, issue 2
Krutika Sawant, Kailash C. Petkar, Sandip S. Chavhan, Snezana Agatonovik-Kustrin